CD30 Regulation of IL-13–STAT6 Pathway in Breast Implant–Associated Anaplastic Large Cell Lymphoma
Marshall E. Kadin(Roger Williams Medical Center), Yibin Yang(Fox Chase Cancer Center)
Cited by 7
Related Papers
NOD2 Pathway Activation by MDP or Mycobacterium tuberculosis Infection Involves the Stable Polyubiquitination of Rip2
|Journal of Biological Chemistry|2007|224
Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant–Associated Anaplastic Large-Cell Lymphoma
|American Journal Of Pathology|2019|54
IL-13 Signaling in CD30+ Cutaneous Lymphoproliferative Disorders
|Journal of Investigative Dermatology|2020|5